Alimera Sciences

Aug 05, 2019

New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients

Sep 17, 2018

Alimera Sciences Announces Nine Clinical Presentations and a Sponsored Symposium at 18th EURETINA Congress

Sep 13, 2018

Alimera Sciences Announces Three Podium Presentations for ILUVIEN® to be Presented at 2018 Retina Society's Annual Meeting

Aug 29, 2018

Alimera Sciences to Present at the 20th Annual HC Wainwright Global Investment Conference

Aug 28, 2018

Alimera Sciences to Present at the Annual B. Riley Healthcare Conference

Jul 11, 2018

Alimera Sciences Announces 8 ILUVIEN® Presentations At The 2018 American Society Of Retina Specialists Annual Meeting

Jun 21, 2018

Alimera Sciences Appoints Mary T. Szela to its Board of Directors

Jun 11, 2018

The UK National Institute For Health And Care Excellence To Undertake A Partial Review Of The ILUVIEN Reimbursement Guidance Allowing Broader Availability

May 31, 2018

Alimera Sciences Announces the Reimbursement of ILUVIEN® in Spain

May 22, 2018

Alimera Sciences to Present at the 8th Annual LD Micro Invitational Conference